Sedaghat N[au] - Search Results

Year	Number of Results
2007	1
2008	1
2010	1
2012	2
2014	2
2015	4
2016	4
2017	6
2018	2
2019	3
2020	3
2021	16
2022	12

1

WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies.

Etemadifar M, Aghababaee A, Sedaghat N, Rayani M, Nouri H, Abhari A, Salari M, Majdinasab N, Ghiasian M, Bayati A, Nabavi SM, Mansouri A. Etemadifar M, et al. Among authors: sedaghat n. Rev Neurol (Paris). 2020 Sep 15:S0035-3787(20)30660-3. doi: 10.1016/j.neurol.2020.08.001. Online ahead of print. Rev Neurol (Paris). 2020. PMID: 33039152 Free PMC article.

2

Acute relapse and poor immunization following COVID-19 vaccination in a rituximab-treated multiple sclerosis patient.

Etemadifar M, Sigari AA, Sedaghat N, Salari M, Nouri H. Etemadifar M, et al. Among authors: sedaghat n. Hum Vaccin Immunother. 2021 Oct 3;17(10):3481-3483. doi: 10.1080/21645515.2021.1928463. Epub 2021 May 20. Hum Vaccin Immunother. 2021. PMID: 34015240 Free PMC article.

3

Movement Disorders Associated with COVID-19.

Salari M, Zaker Harofteh B, Etemadifar M, Sedaghat N, Nouri H. Salari M, et al. Among authors: sedaghat n. Parkinsons Dis. 2021 Nov 8;2021:3227753. doi: 10.1155/2021/3227753. eCollection 2021. Parkinsons Dis. 2021. PMID: 34790346 Free PMC article. Review.

4

Endovascular management of iatrogenic arteriovenous fistula of the breast.

Yanagisawa W, Sedaghat N, Gordon-Thomson D. Yanagisawa W, et al. Among authors: sedaghat n. Breast J. 2021 Jan;27(1):52-55. doi: 10.1111/tbj.14131. Epub 2020 Dec 13. Breast J. 2021. PMID: 33314370

5

Outcome of COVID-19 infection in multiple sclerosis patients receiving disease-modifying therapies.

Etemadifar M, Sami R, Salari M, Sedaghat N, Sigari AA, Aghababaei A, Najafi M, Tehrani DS. Etemadifar M, et al. Among authors: sedaghat n. J Res Med Sci. 2021 Sep 30;26:85. doi: 10.4103/jrms.JRMS_1047_20. eCollection 2021. J Res Med Sci. 2021. PMID: 34760002 Free PMC article.

6

INGOT-DR: an interpretable classifier for predicting drug resistance in M. tuberculosis.

Zabeti H, Dexter N, Safari AH, Sedaghat N, Libbrecht M, Chindelevitch L. Zabeti H, et al. Among authors: sedaghat n. Algorithms Mol Biol. 2021 Aug 10;16(1):17. doi: 10.1186/s13015-021-00198-1. Algorithms Mol Biol. 2021. PMID: 34376217 Free PMC article.

7

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.

Sedaghat N. Sedaghat N. Mult Scler Relat Disord. 2021 Aug;53:103054. doi: 10.1016/j.msard.2021.103054. Epub 2021 May 30. Mult Scler Relat Disord. 2021. PMID: 34102605 Free PMC article. No abstract available.

8

Conus medullaris involvement in demyelinating disorders of the CNS: A comparative study.

Etemadifar M, Salari M, Kargaran PK, Sigari AA, Nouri H, Etemadifar F, Ebrahimi S, Sayahi N, Sedaghat N. Etemadifar M, et al. Among authors: sedaghat n. Mult Scler Relat Disord. 2021 Sep;54:103127. doi: 10.1016/j.msard.2021.103127. Epub 2021 Jul 5. Mult Scler Relat Disord. 2021. PMID: 34261025

9

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

Etemadifar M, Sedaghat N, Aghababaee A, Kargaran PK, Maracy MR, Ganjalikhani-Hakemi M, Rayani M, Abhari AP, Khorvash R, Salari M, Nouri H. Etemadifar M, et al. Among authors: sedaghat n. Mult Scler Relat Disord. 2021 Jun;51:102915. doi: 10.1016/j.msard.2021.102915. Epub 2021 Mar 20. Mult Scler Relat Disord. 2021. PMID: 33799284 Free PMC article.

10

Comparative study of computational methods for reconstructing genetic networks of cancer-related pathways.

Sedaghat N, Saegusa T, Randolph T, Shojaie A. Sedaghat N, et al. Cancer Inform. 2014 Sep 21;13(Suppl 2):55-66. doi: 10.4137/CIN.S13781. eCollection 2014. Cancer Inform. 2014. PMID: 25288880 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results